Related Experiment Videos
Chemoprevention of lung cancer
1Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 432, Houston 77030, USA. edkim@mdanderson.org
Abstract:
Lung cancer is the leading cause of death worldwide. Its overall survival rate has improved only slightly, and surgery, radiotherapy, and chemotherapy remain the mainstays of current treatment. Therapies with novel targeted agents are currently under active investigation in all settings of treatment including chemoprevention, defined as the use of natural or synthetic agents to interrupt the process of carcinogenesis and to prevent or delay tumor occurrence. Thus, chemoprevention describes the collaborative efforts of researchers in basic science and clinical settings who study the biology of lung cancer with the hope of uncovering new mechanisms of treatment. Because lung cancer has become an increasingly difficult problem to treat with standard therapies, chemopreventive strategies have been developed. Small molecule compounds that target specific receptors or mutations will play an increasingly significant role in treatment of lung cancer because the side effect profiles of such agents are tolerable and they may be more effective than other treatments.
Insights
Lung cancer chemoprevention research explores novel targeted agents to interrupt carcinogenesis. These small molecule compounds offer a promising, tolerable, and potentially more effective approach to lung cancer treatment.
Area of Science:
- Oncology
- Cancer Prevention
- Pharmacology
Background:
- Lung cancer remains a leading global cause of mortality with limited improvements in survival rates.
- Current standard treatments including surgery, radiotherapy, and chemotherapy have shown modest efficacy.
- Developing novel therapeutic strategies is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the role of chemoprevention in interrupting lung cancer development.
- To explore the potential of novel targeted agents in lung cancer treatment.
- To highlight the significance of small molecule compounds in future lung cancer therapies.
Main Methods:
- Active investigation of targeted agents across all treatment settings.
- Focus on chemoprevention strategies to prevent or delay tumor occurrence.
- Research into the biological mechanisms of lung cancer.
Main Results:
- Novel targeted agents are under active investigation for lung cancer.
- Chemoprevention strategies are being developed to combat difficult-to-treat lung cancers.
- Small molecule compounds show potential for improved efficacy and tolerable side effect profiles.
Conclusions:
- Chemoprevention represents a collaborative effort between basic science and clinical research.
- Targeted small molecule compounds are expected to play a significant role in future lung cancer treatment.
- These agents offer a promising avenue for more effective and safer lung cancer therapies.